NEURELIS PRESENTS NOVEL, INVESTIGATIONAL ANALYSIS OF valtoco® (DIAZEPAM NASAL SPRAY) civ demonstrating increased time between seizure clusters AT THE 51st Child Neurology Society Annual Meeting

/PRNewswire/ -- Neurelis, Inc., today announced findings from a novel, investigational analysis of the time between seizure clusters in pediatric patients...

Related Keywords

Ohio ,United States ,Cincinnati ,Adrian Rabinowicz ,Brittany Bradrick ,Prnewswire Neurelis Inc ,Neurelis Inc ,Child Neurology Society Annual Meeting ,Drug Administration ,Clinical Development ,Lennox Gastaut Syndrome ,Over Time ,Pediatric Patients ,Long Term Open Label ,Repeat Dose Safety Study ,Diazepam Nasal Spray ,Seizure Clusters ,Lennox Gastaut Syndrome Respond Differently ,Final Safety ,Effectiveness Results From ,Neurelis Orphan Drug Exclusivity ,Safety Information ,Nervous System ,Serious Adverse Reactions ,Benzyl Alcohol ,Prescribing Information ,Boxed Warning ,Chief Financial Officer ,